Prognostic Contribution of Abdominal Ultrasound in Necrotizing Enterocolitis in Preterm Infants Less Than 33SA.
NCT ID: NCT02872350
Last Updated: 2016-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
95 participants
INTERVENTIONAL
2016-10-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The diagnosis of ECUN based on clinical and radiological criteria. The abdomen plain film to date is the reference examination to confirm or refute the diagnosis. Indeed, the presence of pathognomonic signs (pneumatosis, aéroportie) on the abdomen of cliché can confirm the diagnosis. The prognostic value of these radiographic findings is currently controversial.
Abdominal ultrasound is a test whose possibilities in diagnostic and prognostic term began to be considered for some years. It also has other advantages, including that of not being a radiating examination. Studies on the prognostic value of abdominal ultrasound are rather few. Moreover, they involve a series of heterogeneous patients in terms of gestational age. Or the pathophysiology of ECUN in children born at term and in children born prematurely is not the same.
The objective is to study prospectively the prognostic contribution of abdominal ultrasound in the ECUN in premature under 33SA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound, Doppler ,and Calprotectin in Necrotizing Enterocolitis Diagnosis
NCT03257553
Imaging Modalities in Diagnosing Necrotizing Enterocolitis in Preterm Infants.
NCT03188380
Prenatal Ultrasound Screening of Intestinal Malrotation With a Higher Risk of Volvulus
NCT03356314
NEC Screening Abdominal Radiograph vs Bowel Ultrasound in Preemies
NCT03963011
Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus.
NCT05148429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premature with necrotizing enterocolitis
Abdominal ultrasound
Techniques and predictive characteristics of the combination abdominal ultrasound abdomen and shot in the prognostic assessment of ECUN in premature under 33SA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abdominal ultrasound
Techniques and predictive characteristics of the combination abdominal ultrasound abdomen and shot in the prognostic assessment of ECUN in premature under 33SA.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age some (assessed on early ultrasound dating)
* Congenital malformation of Absence
* Suggestive clinical symptomatology of ECUN defined by the presence of abdominal bloating, increased residues (\> 20% of the volume of enteral feeding) and the presence of blood in stool (macro- or microscopic)
* Radiologic investigation with a radiograph of abdomen and abdominal ultrasound done for the episode of ECUN
* Maximum interval between imaging tests 2 hours
* No parental opposition to the participation of children in the study
Exclusion Criteria
* Congenital malformation
* Parental Opposition (or legal representatives) to participate in the study
33 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Hôpitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A01628-41
Identifier Type: REGISTRY
Identifier Source: secondary_id
2015-34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.